ABOUT THE CONFERENCE
The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present the Fifth International Cancer lmmunotherapy Conference.
The 2019 meeting will be held at the Espace Grande Arche in Paris, France from September 25 - 28, 2019. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism.
This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.
While we encourage your use of social media in and around the conference, we ask that you be aware of the following guidelines:
Follow the conference organizers on Twitter (@CancerResearch, @C_IMT, and @AACR) and use the hashtag #cicon19 for this conference.
Conference attendees may share information from presentations on social media provided that they respect the wishes of presenters. Oral presenters may label any or all slides in their presentations with “DO NOT POST.” Similarly, poster presenters may label their posters with “DO NOT POST.” Attendees must respect the presenters’ requests in these instances and refrain from posting any images from these designated slides or posters on social media.
MEETING POLICIES AND PROCEDURES
Conference attendees may take photographs during oral or poster presentations provided that the photographs are strictly for personal, noncommercial use and are not to be published in any form. Attendees are prohibited from using flash photography or otherwise distracting the presenters or members of the audience.
The Espace Grande Arche is 100% smoke-free; smoking within the venue is prohibited.
Children under 12 years of age are not permitted in any scientific session or poster session at any time. Children cannot be left unattended or unsupervised.
Cell phones, pagers, and other electronic devices must be turned off or placed on “silent” mode before entering a session.
Lost and Found: Attendees may contact the conference Registration Desk for any lost items.
Poster presenters are solely responsible for placing their poster on the assigned poster board and removing their poster according to the schedule provided. The conference organizers cannot be responsible for any posters that are not removed at the designated time. Posters left in the Poster Hall after that time may be discarded.
Poster presenters should not leave any items at their poster board unattended, including poster tubes, meeting bags, Programs, personal items, etc. The conference organizers are not responsible for any items left in the Poster Hall.
PLanning Committee Members
Christoph Huber, Association for Cancer Immunotherapy, Mainz, Germany
Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France
Ellen Puré, University of Pennsylvania, Philadelphia, Pennsylvania
Giorgio Trinchieri, National Cancer Institute, Frederick, Maryland
scientific planning committee
Sandra Demaria, Weill Cornell Medical College, New York, New York
Wolf Hervé Fridman, Centre de Recherche des Cordeliers, Paris, France
Nir Hacohen, Massachusetts General Hospital and Broad Institute, Cambridge, Massachusetts
Sebastian Kreiter, Johannes Gutenberg University, Mainz, Germany
Cornelis J. M. Melief, Leiden University Medical Center & ISA Pharmaceuticals, Leiden, The Netherlands
Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York
Catherine Sautès-Fridman, Université Paris-Descartes, Paris, France
Robert D. Schreiber, Washington University School of Medicine, St. Louis, Missouri
Özlem Türeci, BioNTech AG, Mainz, Germany
E. John Wherry, Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
Laurence Zitvogel, Institut Gustave Roussy, Paris, France